Skip to main content
Premium Trial:

Request an Annual Quote

Pushback on Mosquito Paper

A new paper says that an effort to introduce gene drives into mosquitos to reduce their numbers has not gone as planned, but the company behind that effort argues the paper is flawed, New Atlas reports.

The British firm Oxitec has developed modified male mosquitos that, when they mate with wild female mosquitos, the resulting larvae don't survive to adulthood. In a trial in Brazil, the firm had reported that their approach led to an 82 percent decrease in the number of wild mosquito larvae.

But researchers from the US and Brazil say in a Scientific Reports paper that they monitored the Aedes aegypti population at that Brazilian test site and report that parts of transgenic mosquito's genome has become incorporated into the local wild mosquito population, something that was not supposed to occur.

However, Oxitec tells Gizmodo that the new paper includes "numerous false, speculative, and unsubstantiated claims and statements about Oxitec's mosquito technology." The firm adds in a statement on its site that there were no negative effects on people.

The paper currently has a notice indicating that the journal is aware of and is looking into criticisms of the paper's conclusions, and, according to Gizmodo, Oxitec says it is working with the journal to have the paper corrected or removed.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.